TracVac | Developing a Chlamydia Trachomatis vaccine 01-03-2017 - 28-02-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases
CCHFVaccine | Crimean-Congo Haemorrhagic Fever Vaccine 01-01-2017 - 31-12-2024 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases
MultiViVax | Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria 01-01-2017 - 31-12-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases
ZIKAVAX | Fast track development of a Zika vaccine based on measles vector 01-10-2016 - 31-12-2020 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases
RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine 01-01-2017 - 31-12-2021 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases
OptiMalVax | Optimizing a deployable high efficacy malaria vaccine 01-01-2017 - 31-12-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.2. Preventing disease H2020-SC1-2016-RTD SC1-PM-06-2016 Vaccine development for malaria and/or neglected infectious diseases